Shire Human Genetic Therapies
GPTKB entity
Properties (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Shire_plc
|
| gptkbp:collaboratesWith |
academic institutions
research organizations |
| gptkbp:employees |
approximately 200
|
| gptkbp:focusesOn |
genetic disorders
|
| gptkbp:founded |
2008
|
| gptkbp:hasPart |
quality assurance
clinical trials patient advocacy manufacturing facilities regulatory affairs marketing and sales |
| gptkbp:headquarters |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Shire Human Genetic Therapies
|
| gptkbp:partOf |
gptkb:Shire_plc
|
| gptkbp:products |
gptkb:Elaprase
gptkb:Glybera Cerezyme Replagal Vpriv |
| gptkbp:researchFocus |
rare diseases
|
| gptkbp:specializesIn |
enzyme replacement therapy
|